BPA for jynarque
Active Awarded Last action
- Contract number
- 36E79725A0011
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 1 $20,378 obligated
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Combined order value
- $20,378 Current and potential, with all options
- Last date to order 80% complete
- IDV ceiling <1% used
- $83,342,090.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center established a Blanket Purchase Agreement with Otsuka America Pharmaceutical Inc. on March 27, 2025, against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a ceiling of $83.342 billion and an ultimate completion date of March 26, 2027.
The BPA procures Jynarque (tolvaptan) and related pharmaceutical products for the Department of Veterans Affairs. Place of performance is nationwide, supporting VA Integrated Service Networks across the United States. The FSS-61-IB parent schedule covers specialty pharmaceuticals and hematology-related products for federal healthcare systems.
Delivery orders issued under this BPA have ranged from $10,000 to $113,000 per order, distributed across multiple VA regional networks including VISN 5, VISN 6, VISN 20, VISN 21, and VISN 22, each on a firm-fixed price basis.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Jynarque 45MG, 15 MG | Veterans Integrated Service Network 5 (VHA) | $20,378 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725A0011?
36E79725A0011 was awarded to Otsuka America Pharmaceutical Inc. by National Acquisition Center (Headquarters) on March 27, 2025.
How much is contract 36E79725A0011 worth?
Orders under 36E79725A0011 have obligated $20,378. 36E79725A0011's own ceiling is $83,342,090.
How many orders have been placed under contract 36E79725A0011?
1 order has been placed under 36E79725A0011, the latest on July 30, 2026.
Who can order from contract 36E79725A0011?
36E79725A0011 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79725A0011 under another contract?
Yes. 36E79725A0011 is a blanket purchase agreement under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79725A0011 competed?
The extent of competition for 36E79725A0011 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV